医学
金念珠菌
回顾性队列研究
血流感染
队列研究
队列
多中心研究
菌血症
儿科
重症监护医学
内科学
微生物学
皮肤病科
抗生素
随机对照试验
抗真菌
生物
作者
Adriana Jiménez,Rossana Rosa,Samantha M. Ayoub,Rachel Guran,Sebastian Arenas,Nickolas Valencia,Janna C Stabile,Adrian Estepa,Dipen J. Parekh,Tanira Ferreira,Hayley B. Gershengorn,Kavitha Prabaker,Paula Eckardt,Matthew Zahn,Lilian M. Abbo,Bhavarth Shukla
摘要
Abstract Background Candida auris has become a growing concern worldwide because of increases in incidence of colonization and reports of invasive infections. There are limited data on clinical factors associated with poor outcomes in patients with C. auris bloodstream infection (BSI). Methods We assembled a multicenter retrospective cohort of patients with C. auris BSI from 2 geographics areas in US healthcare settings. We collected data on demographic, clinical, and microbiologic characteristics to describe the cohort and constructed multivariate logistic regression models to understand risk factors for 2 clinical outcomes, all-cause mortality during facility admission, and blood culture clearance. Results Our cohort consisted of 187 patients with C. auris BSI (56.1% male, 55.6% age >65 years); 54.6% died by facility discharge and 66.9% (of 142 with available data) experienced blood culture clearance. Pitt bacteremia score at infection onset was associated with mortality (odds ratio [95% confidence interval]: 1.19 [1.01–1.40] per 1-point increase). Hemodialysis was associated with a reduced odds of microbiologic clearance (0.15 [0.05–0.43]) and with mortality (3.08 [1.27–7.50]). Conclusions The Pitt bacteremia score at the onset of C. auris BSI may be a useful tool in identifying patients at risk for mortality. Targeted infection prevention practices in patients receiving hemodialysis may be useful to limit poor outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI